Particularly, they are likely to develop hypercalcemia 4, 5, resulted from the elevated expression of the parathyroid-hormone-related protein (PTHRP) and the activation of stanniocalcin-1 signaling mediated by IL-6 71. The gene discussed is PTHLH; the disease is hypercalcemia disease.